The World Health Organization (WHO) has recently approved the Alinity m MPXV assay, a real-time PCR diagnostic test for mpox that provides immediate results.
About recent Mpox Diagnosis
The “real-time PCR test”, Alinity m MPXV assay enables the detection of the virus by testing swabs of skin lesions.
Immediate Results: Previously, patients often waited days for test results. This new test will enable health workers to confirm suspected mpox cases more efficiently, which is crucial for controlling outbreaks.
Global Impact: Mpox has been detected in 16 African countries this year, leading to over 800 deaths. The WHO notes that limited testing capacity and delays in confirming cases contribute to the continued spread of the virus.
Emergency Use Listing: The Alinity m MPXV assay is the first mpox diagnostic test to be listed under the WHO's Emergency Use Listing (EUL) procedure, which allows for the expedited availability of unlicensed tests during public health emergencies.
What is Mpox?
Mpox, formerly known as monkeypox, is a viral zoonotic disease caused by the mpox virus.
It primarily spreads through human-to-human contact and contact with infected animals.
The disease can manifest with symptoms including fever, aches, and skin lesions.
Recent outbreaks, particularly in Africa, have raised significant public health concerns, prompting international health organizations to take action.